Paolo Tralongo - Concepedia

Author

Paolo Tralongo

Also Known As

Alessandro D'Angelo, D. Toniolo, P Tralongo, P. Tralongo, PAOLO TRALONGO, Paolo Tralongo, Tralongo Paolo, Tralongo, Paolo, ilaria Toscani

102

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Ospedali Riuniti Umberto I Fondazione Vincenzo Pansadoro La Maddalena Istituti di Ricovero e Cura a Carattere Scientifico Nuovo Ospedale San Giovanni di Dio

About

Paolo Tralongo is an author at Ospedali Riuniti Umberto I specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	581
2	Health Sciences	3	3	80
3	Nursing	3	3	198
4	Arts	1	1	32
5	Education	1	1	21

Paolo Tralongo

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey Massimiliano Berretta, Chiara Della Pepa, Paolo Tralongo, Oncotarget	2016	144
The prevalence and correlates of fatigue in older cancer patients Daniela Respini, Paul B. Jacobsen, Christina Thors, Critical Reviews in Oncology/Hematology NursingGeriatric OncologyFatigue ManagementAgingHealthy Aging	2003	100
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC) Francesco Di Costanzo, Paolo Carlini, Laura Doni, British Journal of Cancer	2005	98
Categorization of Cancer Survivors: Why We Need It Antonella Surbone, Paolo Tralongo Journal of Clinical Oncology Family MedicineCancer ManagementCancer RegistrationCancer EducationGynecology Oncology	2016	73
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study Massimiliano Berretta, Luca Rinaldi, R. Taibi, Frontiers in Oncology	2020	69
Cancer patient-centered home care: a new model for health care in oncology Vittorio Gebbia, Vittorio Gebbia, Borsellino, Therapeutics and Clinical Risk Management	2011	62
Long-term quality of life profile in oncology: a comparison between cancer survivors and the general population Maria Antonietta Annunziata, Barbara Muzzatti, Cristiana Flaiban, Supportive Care in Cancer Family MedicineQuality Of LifeLife AssessmentLong-term QualityLongevity	2017	56
Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer Vittorio Gebbia, M Bellavia, Giuseppe Luigi Banna, Clinical Lung Cancer Second-line ErlotinibTreatment Monitoring ProgramOncologyCancer ManagementPharmacotherapy	2013	54
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice Vittorio Gebbia, Evaristo Maiello, Francesco Giuliani, Annals of Oncology Surgical OncologyFolfox4 RegimenPancreatic CancerGastrointestinal OncologyMedicine	2007	54
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study Marina Elena Cazzaniga, G. Pinotti, Emilia Montagna, The Breast Victor-6 StudyBreast OncologyOncologyMetronomic TherapyBreast Cancer	2019	52

Page 1